(Q69490314)
Statements
A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma (English)
S Creekmore
G R Weiss
K Margolin
A B Markowitz
M Roper
D Parkinson
N Ciobanu
R I Fisher